All News #Library
Biotech
Actym Gets IND Clearance For Phase 1 Trial Of ACTM-838 In Solid Tumors
30 May 2024 //
PR NEWSWIRE
Actym to Present Preclinical Data on Clinical Candidate ACTM-838
03 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support